RCEL Stock Analysis: Buy, Sell, or Hold?
RCEL - Avita Medical, Inc. Common Stock
$4.56
0.20 (4.59%)
▲
5d:
+10.95%
30d:
-8.62%
90d:
+9.62%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Smart Money Distribution
RCEL is up 4.5% this week, but smart money is buying puts. Top strike: $5 2026-07-17 with 231 OI. Put ratio: 100% View Scanner →
Strength: 7.2/10
Get Alerted When RCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RCEL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: RCEL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: RCEL is currently trading at $4.56, which is considered fair relative to its 30-day fair value range of $4.12 to $4.91. From a valuation perspective, the stock is trading at a discount (Forward PE: -16.3) compared to its historical average (8.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, RCEL is in a uptrend. Immediate support is located at $4.01, while resistance sits at $5.59. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: RCEL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.60 (+88.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RCEL is in a uptrend. Immediate support is located at $4.01, while resistance sits at $5.59. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: RCEL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.60 (+88.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.12 -
$4.91
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.9%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.6%)
- BULLISH: Trading 88.6% below Wall St target ($8.60)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$4.12 -
$4.91
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$4.01
Resistance Level
$5.59
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.31
Wall Street Target
$8.60
(+88.6%)
Revenue Growth (YoY)
-4.3%
Profit Margin
-67.8%
PE vs Historical
-16.3 vs 8.0
CHEAP
Share & Embed Analysis
Last updated: May 18, 2026 5:04 AM ET
Data refreshes hourly during market hours. Next update: 6:04 AM
Data refreshes hourly during market hours. Next update: 6:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RCEL showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
David D O'toole
BUY
3000 shares
2026-02-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
